Pacira Pharmaceuticals, Inc., a leading biopharmaceutical company headquartered in the United States, focuses on innovative solutions for pain management and surgical care. Founded in 2006, Pacira has made significant strides in the industry, particularly with its flagship product, EXPAREL, a long-acting local anaesthetic that enhances postoperative pain control while reducing the need for opioids. With a commitment to advancing patient care, Pacira operates primarily in North America and has expanded its reach into various surgical specialties. The company is recognised for its unique approach to pain management, positioning itself as a pioneer in the development of non-opioid therapies. Notable achievements include a strong market presence and partnerships that further its mission to improve surgical outcomes and patient recovery.
We don't have data for Pacira Pharmaceuticals, Inc., but we can show you information about their parent organization instead.
View parent company